ABCC7 p.Gln1291His

[switch to full view]
Comments [show]
Publications
PMID: 11536079 [PubMed] Le Saux O et al: "A spectrum of ABCC6 mutations is responsible for pseudoxanthoma elasticum."
No. Sentence Comment
145 Moreover, an identical mutation in ABCC7 (CFTR [GenBank accession number NM_000492]), which is responsible for cystic fibrosis, involved the same glutaminyl residue, Q1291H (3873GrC), at the last nucleotide of exon 20 of the ABCC7 gene and resulted in a glutaminyl-to-histidinyl residue substitution.
X
ABCC7 p.Gln1291His 11536079:145:166
status: NEW
Login to comment

146 RNA-based PCR analysis revealed that Q1291H in the ABCC7 gene was also a splice mutation.
X
ABCC7 p.Gln1291His 11536079:146:37
status: NEW
Login to comment

147 Both correctly and aberrantly spliced mRNAs were produced from the Q1291H allele.
X
ABCC7 p.Gln1291His 11536079:147:67
status: NEW
Login to comment

PMID: 16086317 [PubMed] Miksch S et al: "Molecular genetics of pseudoxanthoma elasticum: type and frequency of mutations in ABCC6."
No. Sentence Comment
191 An ''analogous mutation`` (Q1291H) in ABCC7 (CFTR) that is responsible for the development of cystic fibrosis, and for which alteration of the splice donor site was demonstrated by mRNA studies [Jones et al., 1992], has also been described.
X
ABCC7 p.Gln1291His 16086317:191:27
status: NEW
Login to comment

PMID: 10915765 [PubMed] Nissim-Rafinia M et al: "Cellular and viral splicing factors can modify the splicing pattern of CFTR transcripts carrying splicing mutations."
No. Sentence Comment
13 Among these are mutations leading to inclusion of intronic sequences, such as 3849+10kb C→T (2), 1811+1.6kb A→G (3) and Q1291H (4), and mutations leading to the skipping of CFTR exons, such as 1898+5 G→T (5) and the polymorphic alleles at IVS8-Tn site (5T, 7T and 9T alleles) (6).
X
ABCC7 p.Gln1291His 10915765:13:134
status: NEW
Login to comment

PMID: 11341822 [PubMed] Zou X et al: "ATP hydrolysis-coupled gating of CFTR chloride channels: structure and function."
No. Sentence Comment
194 Interestingly, even relatively conserved mutations of these two glutamine residues (e.g., Q493R in NBD1 and Q1291R or Q1291H in NBD2) in the CFTR cause CF (Figure 3).
X
ABCC7 p.Gln1291His 11341822:194:118
status: NEW
Login to comment

PMID: 11788611 [PubMed] Berger AL et al: "Mutations that change the position of the putative gamma-phosphate linker in the nucleotide binding domains of CFTR alter channel gating."
No. Sentence Comment
211 Two relatively uncommon missense mutations have been described at Gln-1291, Q1291H and Q1291R (43),4 and a single chromosome was reported to encode a variation at Gln-493, Q493R.4 The relatively mild gating abnormalities we observed for these variants suggest that if they cause CF, altered processing or some other abnormality may be the cause for the loss of CFTR function.
X
ABCC7 p.Gln1291His 11788611:211:76
status: NEW
Login to comment

PMID: 20059485 [PubMed] Dorfman R et al: "Do common in silico tools predict the clinical consequences of amino-acid substitutions in the CFTR gene?"
No. Sentence Comment
64 Mutations in the CFTR gene grouped by clinical category Cystic fibrosis CFTR-related disease No disease T338I D614G L320V V920L L90S M470V H199R S1251N I203M G550R P111A I148T Q1291H R560K L1388Q L183I R170H I1027T S549R D443Y P499A L1414S T908N R668C S549N A455E E1401K Q151K G27E I1234L Y563N R347P C866R S1118C P1290S R75Q A559T V520F P841R M469V E1401G P67L G85E S50Y E1409K R933G G458V G178R Y1032C R248T I980K G85V V392G L973P L137H T351S R334W I444S V938G R792G R560T R555G L1339F D1305E P574H V1240G T1053I D58G G551D L1335P I918M F994C S945L L558S F1337V R810G D1152H G1247R P574S R766M D579G W1098R H949R F200I R352Q L1077P K1351E M244K L206W M1101K D1154G L375F N1303K R1066C E528D D110Y R347H R1070Q A800G P1021S S549K A1364V V392A damaging` (is supposed to affect protein function or structure) and 'probably damaging` (high confidence of affecting protein function or structure).
X
ABCC7 p.Gln1291His 20059485:64:176
status: NEW
Login to comment

PMID: 22658665 [PubMed] Ooi CY et al: "Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in pancreatitis."
No. Sentence Comment
855 CFTR mutation Total PI Total PI + PS PIP score CFTR mutation Total PI Total PI + PS PIP score 621+1G>T 96 96 1.00 G542X 74 75 0.99 711+1G>T 36 36 1.00 F508del 1276 1324 0.96 I507del 34 34 1.00 1717-1G>A 20 21 0.95 R553X 24 24 1.00 W1282X 19 20 0.95 Q493X 11 11 1.00 N1303K 45 48 0.94 S489X 11 11 1.00 R1162X 12 13 0.92 1154insTC 10 10 1.00 Y1092X 12 13 0.92 3659delC 9 9 1.00 I148T 10 11 0.91 CFTRdele2 7 7 1.00 V520F 9 10 0.90 4016insT 7 7 1.00 G551D 59 67 0.88 E60X 7 7 1.00 L1077P 5 6 0.83 R560T 7 7 1.00 R1066C 5 6 0.83 R1158X 7 7 1.00 2184insA 9 12 0.75 3905insT 6 6 1.00 2143delT 3 4 0.75 I148T;3199del6 5 5 1.00 1161delC 3 4 0.75 2183AA>G 5 5 1.00 3120+1G>A 3 4 0.75 1898+1G>A 5 5 1.00 S549N 3 4 0.75 2347delG 4 4 1.00 G85E 16 22 0.73 Q1313X 3 3 1.00 R117C 2 3 0.67 Q220X 3 3 1.00 M1101K 19 30 0.63 2184delA 3 3 1.00 P574H 3 5 0.60 1078delT 3 3 1.00 474del13BP 1 2 0.50 L1254X 3 3 1.00 R352Q 1 2 0.50 E585X 3 3 1.00 Q1291H 1 2 0.50 3876delA 2 2 1.00 A455E 18 37 0.49 S4X 2 2 1.00 R347P 6 15 0.40 R1070Q 2 2 1.00 2789+5G>A 6 16 0.38 F508C 2 2 1.00 L206W 6 18 0.33 DELI507 2 2 1.00 IVS8-5T 4 16 0.25 Q1411X 2 2 1.00 3272-26A>G 1 4 0.25 365-366insT 2 2 1.00 R334W 1 10 0.10 R709X 2 2 1.00 3849+10kbC>T 2 22 0.09 1138insG 2 2 1.00 P67L 1 14 0.07 CFTRdele2-4 2 2 1.00 R117H 1 25 0.04 3007delG 2 2 1.00 R347H 0 5 0.00 Q814X 2 2 1.00 G178R 0 3 0.00 394delTT 2 2 1.00 E116K 0 2 0.00 406-1G>A 2 2 1.00 875+1G>C 0 2 0.00 R75X 2 2 1.00 V232D 0 2 0.00 CFTRdel2-3 2 2 1.00 D579G 0 2 0.00 E193X 2 2 1.00 L1335P 0 2 0.00 185+1G>T 2 2 1.00 Mild mutations (based on PIP scores) are shaded in gray.
X
ABCC7 p.Gln1291His 22658665:855:923
status: NEW
Login to comment

PMID: 22423042 [PubMed] Gonska T et al: "Role of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) in patients with chronic sinopulmonary disease."
No. Sentence Comment
66 All P values are two-sided with a Table 2-CFTR Genotypes Identified in Subjects With Idiopathic Sinopulmonary Disease CF Causing/CF Causing CF Causing/CFTR Mutation CFTR Mutation/CFTR Mutation CF Causing/Unknown CFTR Mutation/Unknown F508del/A455E 3x F508del /D1152H 2x D579G/D579G 2x F508del /26x R764X/2 F508del/S1251N R75X/V456A 758delC/2 F508del/L967S 1716G.A/5T 1716G.A/2 F508del/5T R75Q/5T R117H (7T)/23x F508del/3212T.C 5T/23x G542X/D1152H 1717-1G.A/Q1291H Patients are grouped according to the identified CFTR alterations on allele 1/allele 2.
X
ABCC7 p.Gln1291His 22423042:66:457
status: NEW
Login to comment

PMID: 7551394 [PubMed] Friedman KJ et al: "Screening Young syndrome patients for CFTR mutations."
No. Sentence Comment
78 Of the 13 Young syndrome patients, we identified one (Patient 5) who was het- CBAVD Dl152H D1270N G576A* R75Q* P67L Rl17H 3849 + 10 KB C > T G551S Rl17H Pancreatic Sufficient, Moderate Pulmonary Symptoms, Normal Sweat Chloride Concentrations Pancreatic Sufficient, Moderate Pulmonary Symptoms R347P 2789 + 5 G > A R334W G85E R347H R347L Rl17H G91R A455E S945L Y563N Q1291H R297Q R352Q L1065P 3850-3 T > G F1286S 3849 + 10 KB C > T TABLE 1 CFTR MUTATION SCREENING PANEL Severe M508 G551D R553X N1303K W1282X G542X 1717-1 G > A ~1507 R560T 3659deiC 621 + 1 G > T S549N TABLE 2 CLINICAL FEATURES OF YOUNG SYNDROME PATIENTS Patient Age Sweat CI- FEV, Paranasal Sputum No.
X
ABCC7 p.Gln1291His 7551394:78:366
status: NEW
Login to comment

PMID: 7525450 [PubMed] Dork T et al: "Detection of more than 50 different CFTR mutations in a large group of German cystic fibrosis patients."
No. Sentence Comment
111 Alternatively, it could affect the correct splicing of exon 20 in a similar way as described for the Q1291H mutation in the same codon (Jones et al. 1992).
X
ABCC7 p.Gln1291His 7525450:111:101
status: NEW
Login to comment

PMID: 7513293 [PubMed] Chillon M et al: "Analysis of the CFTR gene confirms the high genetic heterogeneity of the Spanish population: 43 mutations account for only 78% of CF chromosomes."
No. Sentence Comment
31 At present, we have not detected any Spanish CF chromosomes bearing any of the following mutations: 394delTA, Y122X, 556delA, 852de122, R347P, $492F, 1677delTA, V520F, Q552X, R553X, L559S, R560K, R560T, Y563N, P564H, 2043delG, 3320ins5, R1066H, A1067T, H1085R, 3732delA, 3737delA, I1234V, S1255P, 3898insC, Q1291H or 4005+ 1G---~A.
X
ABCC7 p.Gln1291His 7513293:31:307
status: NEW
Login to comment

PMID: 7508414 [PubMed] Cuppens H et al: "Detection of 98.5% of the mutations in 200 Belgian cystic fibrosis alleles by reverse dot-blot and sequencing of the complete coding region and exon/intron junctions of the CFTR gene."
No. Sentence Comment
67 A mutation of the last nucleotide of an exon could cause aberrant splicing, as has been shown for the Q1291H mutation in the CFTR gene (12) and, therefore, E528E could still be the basic defect in this CF allele.
X
ABCC7 p.Gln1291His 7508414:67:102
status: NEW
Login to comment

92 However, this mutation involves the last nucleotide of an exon and could result in aberrant splicing, as has been shown for the Q1291H mutation (12), resulting in a truncated protein.
X
ABCC7 p.Gln1291His 7508414:92:128
status: NEW
Login to comment

66 A mutation of the last nucleotide of an exon could cause aberrant splicing, as has been shown for the Q1291H mutation in the CFTR gene (12) and, therefore, E528E could still be the basic defect in this CF allele.
X
ABCC7 p.Gln1291His 7508414:66:102
status: NEW
Login to comment

91 However, this mutation involves the last nucleotide of an exon and could result in aberrant splicing, as has been shown for the Q1291H mutation (12), resulting in a truncated protein.
X
ABCC7 p.Gln1291His 7508414:91:128
status: NEW
Login to comment

PMID: 1279852 [PubMed] Tsui LC et al: "The spectrum of cystic fibrosis mutations."
No. Sentence Comment
123 8 NO. 11 m []~EVIEWS G551D R553Q G551S I L558S aI~7 S5491 I I 1&559T A455F E5040 I&F508 V520F SS49NII IIR560T PS74H I G458V G480C $492F /" • ss,9 II III* oa. / III / NBF1 ~t ~t NBF2 I I I I I III I I I 11234V G1244E IS1255P D1270N II I Q1291H N1303K G1349D S1251N W1282R] F1286S N1303H Q1283M, FIG[] Cystic fibrosis (missense) mutations located within the two presumptive ATP-binding domains (NBF1 and NBF2) of CFTR.
X
ABCC7 p.Gln1291His 1279852:123:244
status: NEW
Login to comment

PMID: 1281032 [PubMed] Super M et al: "Milestones in cystic fibrosis."
No. Sentence Comment
164 Mutations encountered elsewhere in UK but not yet m N-W 1154insTC R347P A455E G458V Q493X C524X S549N R1283M Q1291H 199 (in the north-west group) 199 199 0 0 0 199 199 0 icant alteration in function appears to be worse than no CFTR being formed at all.
X
ABCC7 p.Gln1291His 1281032:164:109
status: NEW
Login to comment

PMID: 1378801 [PubMed] McIntosh I et al: "Cystic fibrosis transmembrane conductance regulator and the etiology and pathogenesis of cystic fibrosis."
No. Sentence Comment
154 One rare mutation, Q1291H, the result of a G-`C change at the last nucleotide in exon 20, results in the use of a cryptic splice site in intron 20 that disrupts the reading frame.
X
ABCC7 p.Gln1291His 1378801:154:19
status: NEW
Login to comment

PMID: 24149827 [PubMed] Ooi CY et al: "Does extensive genotyping and nasal potential difference testing clarify the diagnosis of cystic fibrosis among patients with single-organ manifestations of cystic fibrosis?"
No. Sentence Comment
127 ߤ14/24 (58%) were not identified with two CF-causing mutations: 12 carried one CF-causing mutation (DF508/-(x5); DF508/5 T (x3); DF508/D1152H; R75X/V456A; 1717-1G>A/Q1291H; 1717-1G>A/5 T) and two had no CF-causing mutation (D579G/D579G; -/-).
X
ABCC7 p.Gln1291His 24149827:127:171
status: NEW
Login to comment

PMID: 25887396 [PubMed] Dong Q et al: "Mutating the Conserved Q-loop Glutamine 1291 Selectively Disrupts Adenylate Kinase-dependent Channel Gating of the ATP-binding Cassette (ABC) Adenylate Kinase Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and Reduces Channel Function in Primary Human Airway Epithelia."
No. Sentence Comment
141 We found that Ap5A did not inhibit Clafa; current when Gln-1291 was replaced by amino acids with bulky side chains like phenylalanine (Q1291F), tryptophan (Q1291W), tyrosine (Q1291Y), or histidine (Q1291H).
X
ABCC7 p.Gln1291His 25887396:141:201
status: NEW
Login to comment

181 No significant differences were detected between bars 1, 3, 4, 5, 6, 7, and 8 (one-way ANOVA followed by Holm-Sidak`s method of all pairwise multiple comparisons; wild-type CFTR, n afd; 13; F508del CFTR, n afd; 10; Q1291A CFTR, n afd; 4; Q1291G CFTR, n afd; 4; Q1291F CFTR, n afd; 6; Q1291H CFTR, n afd; 6; Q1291W CFTR, n afd; 6; Q1291Y CFTR, n afd; 6).
X
ABCC7 p.Gln1291His 25887396:181:299
status: NEW
Login to comment

207 Holding voltage was afa;80 mV for wild-type, Q1291W, and Q1291Y CFTR and afa;60 mV for Q1291H, Q1291F, and Q1291F/S1248F CFTR.
X
ABCC7 p.Gln1291His 25887396:207:93
status: NEW
Login to comment